Raymond James Reiterates “Buy” Rating for Knight Therapeutics (KHTRF)  Baseball Daily News

Knight Therapeutics (OTCMKTS:KHTRF)’s stock had its “buy” rating reaffirmed by Raymond James in a research report issued to clients and investors on …